Main Industry
Biotechnology
Main Product/Service
1. Cancer Drugs Development：Breast cancer、Liver cancer、Lung cancer、Colorectal cancer、Kidney cancer、Oral cancer、Skin Cancer…cancer drugs development.
2. Precision Medicine：Tumor metastases detection
3. Stem cell application and development：Focus on epigenetic modification of stem cell which regulate cell differentiation
2. Precision Medicine：Tumor metastases detection
3. Stem cell application and development：Focus on epigenetic modification of stem cell which regulate cell differentiation
Founded Year
2015
Unified Business No.
24722581
Status
Active
Number of Employees
18
Total Paid-in
Capital
355,900,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Our company was founded on January 22, 2015, and the initial capital was NT$40 million, Because of the rapid addition of clinical experimental business and R & D investment, the number of initial capital increases up to NT$355.9 million. Moreover, in recent days, the number of the employees grows from 5 people to 20 people,including( 3 Ph.D. and 14 MSc).
